Key result
Among patients with chest pain and a single troponin below the limit of detection, a low HEART score was associated with a 0% rate of 30-day major adverse cardiac events compared to 11.1% in those with a moderate score.
Why the study?
It is important to quickly and accurately exclude acute coronary syndrome, and this study aimed to exclude acute myocardial infarction using a single troponin value alongside clinical evaluation and ECG.
Does a single high-sensitivity troponin I below the limit of detection safely exclude acute myocardial infarction and predict low 30-day MACE in patients with suspected AMI?
Cohort (n=167)
No
Does a single high-sensitivity troponin I below the limit of detection safely exclude acute myocardial infarction and predict low 30-day MACE in patients with suspected AMI?
A single high-sensitivity troponin I below the limit of detection safely excludes AMI with a very low 30-day MACE rate, particularly in patients with a low-risk HEART score.
Answers are grounded in this paper and cite their sources.
May support early AMI rule-out with undetectable troponin and low HEART score; leaves open prospective validation before practice change.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Seri̇n et al. (2020) conducted a cohort in Chest pain with suspected acute myocardial infarction (n=167). Low HEART score (0-3) with single troponin below limit of detection vs. Moderate HEART score (4-6) with single troponin below limit of detection was evaluated on 30-day major adverse cardiac events (MACE-30) (RR 29.4, 95% CI 1.7-521.5, p=0.001). Among patients with chest pain and a single troponin below the limit of detection, a low HEART score was associated with a 0% rate of 30-day major adverse cardiac events compared to 11.1% in those with a moderate score.
Synapse has enriched 10 related papers. Consider them for comparative context: